Ablation Devices to Be the Fastest Growing Segment in the U.S. Nonvascular Interventional Radiology Device Market
January 23, 2013 — According to Millennium Research Group (MRG), the segment of the U.S. nonvascular interventional radiology device market with the fastest growth and greatest potential is ablation devices, comprising radiofrequency (RF) ablation, cryoablation and microwave ablation devices. The overall market will grow moderately to $295 million by 2017.
Ablation devices offer a minimally invasive alternative to traditional surgical treatment of liver, prostate, kidney and lung cancers, and this segment is growing quickly because of the increasing popularity of minimally invasive treatments and the rising incidence of these soft tissue cancers.
RF ablation is the most established device type, but microwave ablation and cryoablation are growing rapidly, due to some advantages these types of ablation offer. Microwave ablation devices can produce larger ablation zones and don’t suffer as much from the heat sink effect that can handicap RF ablation. Growth in microwave ablation devices has stalled growth in RF ablation, and this segment of the market will slightly decline through 2017.
Microwave ablation devices are currently sold mainly by smaller companies with limited distribution networks. This has made them attractive acquisition targets by more established companies. For example, AngioDynamics, a leader in RF ablation, recently made a large investment in Microsulis, a microwave ablation company.
Cryoablation devices are the only kind of ablation device that can be used to treat prostate cancer. Urologists and interventional radiologists both use cryoablation to treat kidney cancer, using differing techniques.
“Cryoablation is more versatile than other ablation devices because its effects do not need to be permanent,” said MRG Analyst Sean Messenger. “As a result, it can be useful in indications outside of cancer, most prominently in pain palliation, another growing market. Competitors see the opportunity for significant growth, leading Endo Health Solutions, a company with a large pain franchise and a focus on pain palliation, to acquire the top cryoablation manufacturer, HealthTronics, in 2010.”
Millennium Research Group’s U.S. Markets for Nonvascular Interventional Radiology Devices 2013 report includes unit, installed base, average selling price and revenue information, along with market drivers and limiters and competitive landscape for ablation devices, percutaneous drainage catheters and soft tissue biopsy needles in the United States.
For more information: www.MRG.net, www.DecisionResourcesGroup.com
More like this
- Radiofrequency Ablation Growing in Popularity as a Treatment for Cancer
- Peripheral Vascular Market Expected to See Strong Market Growth
- Global Breast Biopsy Device Market Will Grow Steadily
- European Peripheral Vascular Device Market to Grow Strongly Through 2017
- Stem Cell Therapy Market to Grow Rapidly Over Next Decade
ablation growth market in cryoablation
Cryoablation is often linked to prostate treatments since it is the only ablation method being used for treating prostate cancer out of all the ablation methods. Prostate cryoablation is in the mainstream of treatments urologists consider. Several other ablation methods are under study but not approved by the FDA such as HIFU. However, where this article is a bit mis-guided is that cryoablation is growing by large percentages and is being used with increased frequency in Interventional Radiology for renal, liver, lung, bone and pain palliation. The benefit of cryoablation is that it is the ONLY ablation method that allows the interventional radiologist to visualize the ablation treatment. The freezing mechanism is such that it can be seen under CT/MR and Ultrasound guidance. With the other ablation methods, the ablation is not visable under imaging, so the treatment is done somewhat blindly. There is also another cryoablation company that was not included in this article that has a large part of the cryoablation market and seem to be leading the way for innovation in the area of cryoablation. Galil Medical out of Arden Hills, MN. This is a company to watch. They have released four new cryoablation devices in the past 14 months according to a recent press release.